Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL298827 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Angiotensin-converting enzyme in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1808] [GtoPdb: 1613] [UniProtKB: P12821] | ||||||||
ChEMBL | Binding affinity to angiotensin-converting enzyme (unknown origin) assessed as inhibition constant | B | 6.89 | pKi | 130 | nM | Ki | J Med Chem (2016) 59: 10865-10890 [PMID:27690430] |
Neutral endopeptidase/Neprilysin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1944] [GtoPdb: 1611] [UniProtKB: P08473] | ||||||||
ChEMBL | Compound was evaluated for inhibition of recombinant human neprilysin(NEP). | B | 8.66 | pKi | 2.2 | nM | Ki | Bioorg Med Chem Lett (1996) 6: 2437-2440 |
ChEMBL | Binding affinity to neutral endopeptidase (unknown origin) assessed as inhibition constant | B | 8.72 | pKi | 1.9 | nM | Ki | J Med Chem (2016) 59: 10865-10890 [PMID:27690430] |
ChEMBL | Inhibition of human recombinant NEP using Suc-Ala-Ala-Phe-AMC as substrate after 30 mins by fluorimetry | B | 8.82 | pKi | 1.5 | nM | Ki | J Med Chem (2014) 57: 5748-5763 [PMID:24927250] |
Neutral endopeptidase/Neprilysin in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3369] [GtoPdb: 1611] [UniProtKB: P07861] | ||||||||
ChEMBL | Inhibition of neutral endopeptidase (NEP). | B | 8.72 | pKi | 1.9 | nM | Ki | Bioorg Med Chem Lett (1996) 6: 2053-2058 |
ChEMBL | Compound was tested for inhibition of rat kidney neutral endopeptidase | B | 8.72 | pIC50 | 1.9 | nM | IC50 | Bioorg Med Chem Lett (1996) 6: 2097-2102 |
ChEMBL | Concentration for 50% inhibition of activity of rat kidney enkephalinase | F | 8.72 | pIC50 | 1.9 | nM | IC50 | J Med Chem (1986) 29: 751-757 [PMID:3517331] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]